vimarsana.com

Page 5 - செயலில் மருந்து மூலப்பொருள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biophore applies to DCGI for emergency-use approval for Covid treatment drug Aviptadil

Biophore India Pharmaceuticals has approached the Drugs Controller General of India for an emergency-use approval for Aviptadil, which is used in the treatment of moderate to severe cases of Covid.

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onBiophore india pharmaceuticalsDrugs controller generalActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherIophore aviptadilViptadil euaஆந்திரா பிரதேஷ்மருந்துகள் கட்டுப்படுத்தி ஜநரல்செயலில் மருந்து மூலப்பொருள்

Biophore applies to DCGI for emergency-use approval for COVID treatment drug

Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in the treatment of moderate to severe cases of COVID-19.

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onImage sourceBiophore india pharmaceuticalsDrugs controller generalIndia pharmaceuticalsActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherCovid treatment drugOvid treatment medicineCgi approval for covid treatment medicineOvid cases indiaEmergency use drug

Biophore applies for DCGI emergency-use approval for Covid treatment drug

Read more about Biophore applies for DCGI emergency-use approval for Covid treatment drug on Business Standard. Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in Covid treatment

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onBiophore india pharmaceuticalsDrugs controller generalActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherDrug controller general of indiaCgi emergency use approval for aviptadilCovid 19 treatment drugஆந்திரா பிரதேஷ்மருந்துகள் கட்டுப்படுத்தி ஜநரல்செயலில் மருந்து மூலப்பொருள்

Biophore applies for emergency use approval for COVID-19 drug Aviptadil

The Hyderabad-based firm said it has developed the product which is backward integrated with its in-house API (Active Pharmaceutical Ingredient)

Andhra pradeshJagadeesh babu rangisettyModerna covidBiophore india pharmaceuticals onBiophore india pharmaceuticalsDrugs controller generalActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherCovid 19 drugAviptadil covid 19 drugAviptadil biophere drugBiophore ceoஆந்திரா பிரதேஷ்மருந்துகள் கட்டுப்படுத்தி ஜநரல்

Biophore applies to DCGI for emergency-use approval for COVID-19 treatment drug

The company plans to commence commercial production of the product immediately after the approval is received, the Hyderabad-based firm said.

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onBiophore india pharmaceuticalsDrugs controller generalActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherBiophore indiaDrugs controller general of indiaSars cov 2Biophore ceoSulfobutyl ether beta cyclodextrinஆந்திரா பிரதேஷ்மருந்துகள் கட்டுப்படுத்தி ஜநரல்

vimarsana © 2020. All Rights Reserved.